91�Ʋ���

An international consortium co-led by 91�Ʋ���'s Rubén Martínez-Barricarte has discovered a new genetic disorder that causes immunodeficiency and profound susceptibility to opportunistic infections including a life-threatening fungal pneumonia. 

Neil Osheroff and his lab provide foundational research for new Urinary Tract Infection antibiotic. UTIs affect half of all women. Read More

91�Ʋ��� School of Nursing has received a $3 million Health Resources and Services Administration grant from the Department of Health and Human Services to create a training program, standardized set of competencies and certification for community health workers in Tennessee.

The laboratories of Brian Bachmann and Jonathan Irish have developed a method to discover new small molecules that may kill cancer cells by working through the body’s immune system. Read More

For his work on zoonotic threat mitigation, Lars Plate was awarded $50,000 from the 91�Ʋ��� Corporation for Science Advancement and the U.S. Department of Agriculture. Read More

A company co-founded by 91�Ʋ��� mechanical engineering professor Robert J. Webster III has received a breakthrough device designation from the U.S. Food and Drug Administration that could open the door for new diagnostic and therapeutic applications of flexible endoscopy.

Nashville Biosciences LLC and Illumina Inc. today announced an agreement with Amgen to whole-genome sequence approximately 35,000 DNA samples.

By determining how proteins in different areas of the eye’s lens change over time, 91�Ʋ��� researchers have learned more about how they could contribute to the mysterious progression of cataracts—a clouding of the lens that affects more than 65 million people worldwide each year.   Read More

91�Ʋ��� investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney.

College of Arts and Science faculty members Nathan Schley, Allison Walker, and John Yang have each been awarded grants from the National Institutes of Health to continue their groundbreaking chemistry research. The faculty members are conducting big-picture research with practical applications in a variety of health contexts—including drug synthesis, biomolecular conversion, and disease treatment.

91�Ʋ��� researchers in the lab of Erin Calipari, assistant professor of pharmacology and molecular physiology and biophysics, have demonstrated a role for dopamine signaling in novelty-based learning—a finding that could have major impacts on how neurological diseases are treated. Read More

91�Ʋ��� investigators have discovered a molecular mechanism that promotes chronic kidney disease following kidney injury.

An international team of investigators has found that mild to moderate reduction in kidney function may cause cardiovascular disease, even in people without symptoms of heart disease or diabetes.

A 91�Ʋ��� study found that higher levels of excess oxygen given to patients under general anesthesia add risk of injury to the kidneys, lungs and heart.

91�Ʋ���ers in the 91�Ʋ��� University School of Medicine have received three grants totaling $13.6 million from the National Institutes of Health to develop molecular “atlases” of the brain, kidney, eye and other tissues.

An in-depth analysis by 91�Ʋ��� investigators of published research studies supports removing race from the calculation of estimated glomerular filtration rate (eGFR) — an assessment of kidney function.

91�Ʋ���ers from from 91�Ʋ���-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation myocarditis.

Warren Center for Neuroscience Drug Discovery lead researchers discover a therapy that may treat memory loss and slow the progression of Alzheimer’s disease. Read More

91�Ʋ��� research describes a new investigational peptide drug that can penetrate immune and nonimmune cells, and block inflammatory signaling in a preclinical model of atopic dermatitis — eczema.

The School of Medicine Basic Sciences Dean’s Lecture featured renowned immunologist, virologist, and alumnus Dr. Barney S. Graham. In his talk, “Reflections on Pandemics and the Future of Medicine,” Graham discussed his early research experiences leading up to his seminal work on the first experimental COVID-19 vaccines, along with his observations on the pandemic and hopes for the future of medicine.